We're Not Very Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate
Sep 12
Have your own idea? Try our Stock Screener
Markets has moved to Discover
You can now access Markets by navigating to Discover and selecting Markets.
Canadian (TSX) Pharma Industry Analysis
UpdatedSep 20, 2024
DataAggregated Company Financials
Companies72
- 7D0.6%
- 3M-7.4%
- 1Y-8.7%
- YTD2.5%
The Pharma is pretty flat in the last 7 days, but Curaleaf Holdings has stood out, gaining 5.2%. As for the longer term, the industry has declined 12% in the last year. As for the next few years, earnings are expected to grow by 50% per annum.
Industry Valuation and Performance
Has the Canadian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 20 Sep 2024 | CA$18.1b | CA$11.6b | -CA$2,694,675,910.41 | 21x | -6.7x | 1.6x |
| Sun, 18 Aug 2024 | CA$19.9b | CA$11.7b | -CA$2,742,747,277.78 | 22x | -7.3x | 1.7x |
| Tue, 16 Jul 2024 | CA$20.0b | CA$11.7b | -CA$3,183,280,462.54 | 19.3x | -6.3x | 1.7x |
| Thu, 13 Jun 2024 | CA$20.8b | CA$11.8b | -CA$2,770,274,645.88 | 13.1x | -7.5x | 1.8x |
| Sat, 11 May 2024 | CA$24.1b | CA$11.9b | -CA$3,375,957,081.88 | 13.1x | -7.2x | 2x |
| Mon, 08 Apr 2024 | CA$25.7b | CA$11.9b | -CA$3,481,114,387.21 | 8.7x | -7.4x | 2.2x |
| Wed, 06 Mar 2024 | CA$21.1b | CA$12.0b | -CA$4,226,344,866.43 | 8.7x | -5x | 1.8x |
| Fri, 02 Feb 2024 | CA$24.2b | CA$12.3b | -CA$6,712,858,880.00 | 8.8x | -3.6x | 2x |
| Sun, 31 Dec 2023 | CA$17.9b | CA$12.2b | -CA$6,710,823,789.00 | 9.4x | -2.7x | 1.5x |
| Tue, 28 Nov 2023 | CA$17.8b | CA$12.4b | -CA$6,818,754,003.00 | 6.9x | -2.6x | 1.4x |
| Thu, 26 Oct 2023 | CA$16.1b | CA$12.5b | -CA$7,362,526,198.00 | 11.4x | -2.2x | 1.3x |
| Sat, 23 Sep 2023 | CA$20.3b | CA$12.9b | -CA$7,885,382,537.00 | 14.3x | -2.6x | 1.6x |
| Mon, 21 Aug 2023 | CA$14.0b | CA$13.0b | -CA$8,056,955,654.00 | 13.1x | -1.7x | 1.1x |
| Wed, 19 Jul 2023 | CA$15.3b | CA$13.1b | -CA$9,705,045,950.00 | 12.4x | -1.6x | 1.2x |
| Fri, 16 Jun 2023 | CA$14.7b | CA$13.2b | -CA$9,396,356,334.00 | 12.8x | -1.6x | 1.1x |
| Sun, 14 May 2023 | CA$14.7b | CA$13.4b | -CA$10,278,987,555.00 | 10.2x | -1.4x | 1.1x |
| Tue, 11 Apr 2023 | CA$33.5b | CA$13.3b | -CA$9,962,454,155.00 | 11x | -3.4x | 2.5x |
| Thu, 09 Mar 2023 | CA$19.8b | CA$13.9b | -CA$10,360,817,202.00 | 9.1x | -1.9x | 1.4x |
| Sat, 04 Feb 2023 | CA$20.6b | CA$13.6b | -CA$10,145,803,469.00 | 11x | -2x | 1.5x |
| Mon, 02 Jan 2023 | CA$20.2b | CA$13.6b | -CA$10,129,545,508.00 | 14.1x | -2x | 1.5x |
| Wed, 30 Nov 2022 | CA$29.8b | CA$13.7b | -CA$10,234,871,036.00 | 9x | -2.9x | 2.2x |
| Fri, 28 Oct 2022 | CA$28.0b | CA$13.3b | -CA$9,374,006,016.00 | 11x | -3x | 2.1x |
| Sun, 25 Sep 2022 | CA$25.4b | CA$13.3b | -CA$9,378,656,286.00 | 11.2x | -2.7x | 1.9x |
| Tue, 23 Aug 2022 | CA$29.2b | CA$13.0b | -CA$8,905,411,672.00 | 14.5x | -3.3x | 2.2x |
| Thu, 21 Jul 2022 | CA$28.9b | CA$12.2b | -CA$5,864,279,150.00 | 11.6x | -4.9x | 2.4x |
| Sat, 18 Jun 2022 | CA$27.6b | CA$12.3b | -CA$5,816,615,635.00 | 8.2x | -4.7x | 2.2x |
| Mon, 16 May 2022 | CA$33.4b | CA$12.0b | -CA$5,668,435,703.00 | 9.6x | -5.9x | 2.8x |
| Wed, 13 Apr 2022 | CA$40.6b | CA$11.6b | -CA$4,619,416,381.00 | 12.3x | -8.8x | 3.5x |
| Fri, 11 Mar 2022 | CA$40.5b | CA$10.9b | -CA$4,370,932,353.00 | 12.5x | -9.3x | 3.7x |
| Sun, 06 Feb 2022 | CA$48.6b | CA$10.9b | -CA$4,918,116,940.00 | 12.1x | -9.9x | 4.4x |
| Tue, 04 Jan 2022 | CA$53.5b | CA$10.9b | -CA$4,964,951,212.00 | 13x | -10.8x | 4.9x |
| Thu, 02 Dec 2021 | CA$57.2b | CA$10.9b | -CA$4,720,060,943.00 | 14.7x | -12.1x | 5.3x |
| Sat, 30 Oct 2021 | CA$58.4b | CA$10.1b | -CA$4,904,324,585.00 | 15.2x | -11.9x | 5.8x |
| Mon, 27 Sep 2021 | CA$68.2b | CA$10.4b | -CA$6,649,027,777.00 | 16.4x | -10.3x | 6.6x |
Price to Earnings Ratio
-10.3x
Current Industry PE
- Investors are pessimistic on the Canadian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 4.0% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Canadian Healthcare industry?
| CA Market | 1.38% | |
| Healthcare | 0.71% | |
| Pharma | 0.57% | |
| Pharma | 0.57% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CURA Curaleaf Holdings | CA$4.03 | 5.5% +CA$155.8m | -26.1% | PS1.6x | |
| TRUL Trulieve Cannabis | CA$15.21 | 1.3% +CA$37.5m | 85.5% | PS1.8x | |
| CRON Cronos Group | CA$3.02 | 3.1% +CA$34.4m | 4.9% | PS8.4x | |
| NGEN NervGen Pharma | CA$2.72 | 7.9% +CA$14.0m | 32.7% | PB15.3x | |
| GUD Knight Therapeutics | CA$6.13 | 2.2% +CA$13.1m | 39.3% | PS1.8x |
